SCD5
Stearoyl-CoA desaturase 5
Also known as: ACOD4, FADS4, FLJ21032, HSCD5, SCD4, SCD5_HUMAN
Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene
Protein identityUniProt · HPA
- UniProt accession
- Q86SK9
- Gene
- SCD5
- Ensembl
- ENSG00000145284
- Chromosome
- 4
- Canonical length
- 330 aa
- Protein class
- Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted membrane proteins
- Quaternary structure
- Homodimer
OverviewNCBI Gene
Stearoyl-CoA desaturase (SCD; EC 1.14.99.5) is an integral membrane protein of the endoplasmic reticulum that catalyzes the formation of monounsaturated fatty acids from saturated fatty acids. SCD may be a key regulator of energy metabolism with a role in obesity and dislipidemia. Four SCD isoforms, Scd1 through Scd4, have been identified in mouse. In contrast, only 2 SCD isoforms, SCD1 (MIM 604031) and SCD5, have been identified in human. SCD1 shares about 85% amino acid identity with all 4 mouse SCD isoforms, as well as with rat Scd1 and Scd2. In contrast, SCD5 shares limited homology with the rodent SCDs and appears to be unique to primates (Wang et al., 2005 [PubMed 15907797]).[supplied by OMIM, Mar 2008]
Canonical amino-acid sequenceUniProt
330 residues, UniProt reviewed canonical sequence.
>Q86SK9|SCD5
1 MPGPATDAGK IPFCDAKEEI RAGLESSEGG GGPERPGARG QRQNIVWRNV VLMSLLHLGA
61 VYSLVLIPKA KPLTLLWAYF CFLLAALGVT AGAHRLWSHR SYRAKLPLRI FLAVANSMAF
121 QNDIFEWSRD HRAHHKYSET DADPHNARRG FFFSHIGWLF VRKHRDVIEK GRKLDVTDLL
181 ADPVVRIQRK YYKISVVLMC FVVPTLVPWY IWGESLWNSY FLASILRYTI SLNISWLVNS
241 AAHMYGNRPY DKHISPRQNP LVALGAIGEG FHNYHHTFPF DYSASEFGLN FNPTTWFIDF
301 MCWLGLATDR KRATKPMIEA RKARTGDSSALocalizationUniProt · AlphaFold · HPA
Whether an antibody against SCD5 can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Other membrane
- Secreted
- No
- Transmembrane segments
- 4
- Mean surface accessibility (rSASA)
- 0.28
- Highest tissue expression
- 294 nTPM
Expression across tissuesHPA
Tissue
- amygdala: 294 nTPM
- cerebral cortex: 278 nTPM
- spinal cord: 277 nTPM
- midbrain: 276 nTPM
- hippocampal formation: 234 nTPM
- basal ganglia: 229 nTPM
Single-cell type
- oligodendrocyte progenitor cells: 1,527 nCPM
- bergmann glia: 1,083 nCPM
- oligodendrocytes: 940 nCPM
- pituitary stem cells: 632 nCPM
- adrenal cortex cells: 511 nCPM
- epididymal efferent duct absorptive cells: 428 nCPM
Immune cell
- gdT-cell: 3.8 nTPM
- naive CD8 T-cell: 2.6 nTPM
- MAIT T-cell: 2.4 nTPM
- memory CD8 T-cell: 2.2 nTPM
- basophil: 1.6 nTPM
- NK-cell: 1.1 nTPM
Brain region
- medulla oblongata: 647 nTPM
- spinal cord: 567 nTPM
- white matter: 557 nTPM
- cerebellum: 540 nTPM
- basal ganglia: 494 nTPM
- hypothalamus: 489 nTPM
DiseaseUniProt · ClinVar · IEDB · PubMed
Four sources answering four different questions about SCD5.
Disease | AllUniProt
Conditions SCD5 is implicated in, by any mechanism.
- Deafness, autosomal dominant, 79 (DFNA79) MIM:619086
Disease | GeneticClinVar
1 pathogenic / likely-pathogenic of 54 ClinVar records.
Conditions with pathogenic or likely-pathogenic variants.
- Hearing loss, autosomal dominant 79
Genetic constraint and essentialitygnomAD · DepMap
Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.
- gnomAD LOEUF (loss-of-function intolerance)
- 0.93
- gnomAD pLI
- 0
- gnomAD missense Z
- 0.92
- DepMap mean gene effect
- -0.04
- DepMap dependency class
- selective
Cancer expressionTCGA
Across TCGA tumor cohorts, this protein is over-expressed in roughly 4% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).
OntologyGO
Biological processes
Molecular functions
- iron ion binding
- oxidoreductase activity
- palmitoyl-CoA 9-desaturase activity
- stearoyl-CoA 9-desaturase activity
Cellular components
Protein domainsUniProt · Pfam · InterPro
KeywordsUniProt
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads SCD5 as an antibody target. Whether an autoantibody or antibody against SCD5 could matter depends on whether native SCD5 is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
SCD5 is annotated as predominantly intracellular. Intracellular proteins are common autoantibody markers, becoming visible to the immune system after cell injury or altered processing, but are usually markers of disease rather than direct drivers.
Annotation status
The present source text does not explicitly label SCD5 as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...